Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

BIT:DEX - Euronext Milan - IT0005543480 - Common Stock - Currency: EUR

8.12  -0.14 (-1.69%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DEX. DEX was compared to 31 industry peers in the Household Durables industry. DEX has an average financial health and profitability rating. DEX is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
DEX had a positive operating cash flow in the past year.
Of the past 5 years DEX 4 years were profitable.
In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

With a decent Return On Assets value of 4.50%, DEX is doing good in the industry, outperforming 70.97% of the companies in the same industry.
The Return On Equity of DEX (12.43%) is better than 64.52% of its industry peers.
DEX has a Return On Invested Capital of 8.48%. This is in the better half of the industry: DEX outperforms 61.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEX is significantly below the industry average of 16.96%.
The last Return On Invested Capital (8.48%) for DEX is above the 3 year average (7.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.5%
ROE 12.43%
ROIC 8.48%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

DEX has a better Profit Margin (4.43%) than 61.29% of its industry peers.
In the last couple of years the Profit Margin of DEX has declined.
DEX has a better Operating Margin (8.04%) than 74.19% of its industry peers.
In the last couple of years the Operating Margin of DEX has declined.
DEX's Gross Margin of 39.85% is in line compared to the rest of the industry. DEX outperforms 48.39% of its industry peers.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.04%
PM (TTM) 4.43%
GM 39.85%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DEX is creating some value.
The number of shares outstanding for DEX remains at a similar level compared to 1 year ago.
The debt/assets ratio for DEX has been reduced compared to a year ago.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.01 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
DEX has a Altman-Z score of 2.01. This is comparable to the rest of the industry: DEX outperforms 48.39% of its industry peers.
DEX has a debt to FCF ratio of 3.03. This is a good value and a sign of high solvency as DEX would need 3.03 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.03, DEX is doing good in the industry, outperforming 77.42% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that DEX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.40, DEX perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.03
Altman-Z 2.01
ROIC/WACC1.23
WACC6.9%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DEX has a Current Ratio of 1.16. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
DEX has a Current ratio of 1.16. This is in the lower half of the industry: DEX underperforms 70.97% of its industry peers.
A Quick Ratio of 0.90 indicates that DEX may have some problems paying its short term obligations.
DEX has a Quick ratio (0.90) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.9
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for DEX have decreased strongly by -37.18% in the last year.
DEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
The Revenue has grown by 15.68% in the past year. This is quite good.
Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 31.04% on average per year.
EPS 1Y (TTM)-37.18%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-26.75%
Revenue 1Y (TTM)15.68%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%14.08%

3.2 Future

DEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.44% yearly.
The Revenue is expected to grow by 5.26% on average over the next years.
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue Next Year5.62%
Revenue Next 2Y5.39%
Revenue Next 3Y5.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.55, which indicates a very decent valuation of DEX.
Compared to the rest of the industry, the Price/Earnings ratio of DEX is on the same level as its industry peers.
DEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.78.
The Price/Forward Earnings ratio is 8.11, which indicates a very decent valuation of DEX.
Based on the Price/Forward Earnings ratio, DEX is valued a bit cheaper than 70.97% of the companies in the same industry.
DEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 10.55
Fwd PE 8.11
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DEX is valued a bit cheaper than 77.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.7
EV/EBITDA 3.58
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DEX may justify a higher PE ratio.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y12.08%
EPS Next 3Y8.44%

More info and screens

0

5. Dividend

5.1 Amount

DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEXELANCE SPA

BIT:DEX (4/28/2025, 3:59:04 PM)

8.12

-0.14 (-1.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.73%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap218.67M
Analysts88.57
Price Target13.4 (65.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.86%
PT rev (3m)-6.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.49%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.55
Fwd PE 8.11
P/S 0.46
P/FCF 6.7
P/OCF 5.58
P/B 1.28
P/tB N/A
EV/EBITDA 3.58
EPS(TTM)0.77
EY9.48%
EPS(NY)1
Fwd EY12.33%
FCF(TTM)1.21
FCFY14.94%
OCF(TTM)1.45
OCFY17.91%
SpS17.75
BVpS6.33
TBVpS-2.41
PEG (NY)0.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.5%
ROE 12.43%
ROCE 11.66%
ROIC 8.48%
ROICexc 10.69%
ROICexgc 108%
OM 8.04%
PM (TTM) 4.43%
GM 39.85%
FCFM 6.83%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.03
Debt/EBITDA 1.13
Cap/Depr 28.85%
Cap/Sales 1.36%
Interest Coverage 250
Cash Conversion 64.22%
Profit Quality 154.09%
Current Ratio 1.16
Quick Ratio 0.9
Altman-Z 2.01
F-Score7
WACC6.9%
ROIC/WACC1.23
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.18%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-26.75%
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue 1Y (TTM)15.68%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%14.08%
Revenue Next Year5.62%
Revenue Next 2Y5.39%
Revenue Next 3Y5.26%
Revenue Next 5YN/A
EBIT growth 1Y-15.72%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year47.8%
EBIT Next 3Y17%
EBIT Next 5YN/A
FCF growth 1Y157.29%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y97.69%
OCF growth 3Y11.3%
OCF growth 5YN/A